The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Garza-Trevino, E. S.
* Articles by Alexander, W. F.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Garza-Trevino, E. S.
* Articles by Alexander, W. F.

Am J Psychiatry 1989; 146:1598-1601
Copyright © 1989 by American Psychiatric Association


BRIEF REPORTS

Efficacy of combinations of intramuscular antipsychotics and sedative- hypnotics for control of psychotic agitation

ES Garza-Trevino, LE Hollister, JE Overall and WF Alexander
Harris County Psychiatric Center, Houston, TX 77225.

The combination of haloperidol, 5 mg, and lorazepam, 4 mg, was both effective and safe for managing agitated behavior in an open trial with acutely psychotic patients. The combination also appeared to be superior to its individual components when studied in a randomized, nonblind trial. The principle of the combined use of antipsychotics and sedative-hypnotics was further tested by comparing two new combinations: thiothixene, 5 mg, and lorazepam, 4 mg, versus haloperidol, 5 mg, and phenobarbital sodium, 130 mg. These combinations had comparable efficacy and safety, and the level of transquilization approached that produced by the haloperidol-lorazepam combination in the preceding studies.


This article has been cited by other articles:


Home page
FocusHome page
G. Chouinard
The Search for New Off-Label Indications for Antidepressant, Antianxiety, Antipsychotic and Anticonvulsant Drugs
Focus, September 1, 2006; 4(4): 528.
[Full Text] [PDF]


Home page
Emerg. Med. J.Home page
A Yildiz, G S Sachs, and A Turgay
Pharmacological management of agitation in emergency settings
Emerg. Med. J., July 1, 2003; 20(4): 339 - 346.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
R. H. McALLISTER-WILLIAMS and I. N. FERRIER
Rapid tranquillisation: time for a reappraisal of options for parenteral therapy
The British Journal of Psychiatry, June 1, 2002; 180(6): 485 - 489.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. M. Kane
Schizophrenia
N. Engl. J. Med., January 4, 1996; 334(1): 34 - 42.
[Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. Delini-Stula and D. Berdah-Tordjman
Benzodiazepines and GABA hypothesis of schizophrenia
J Psychopharmacol, January 1, 1995; 9(1): 57 - 63.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1989 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org